Literature DB >> 7912348

Epidemiology of hypertension.

P K Whelton1.   

Abstract

Cardiovascular disease is the main cause of death in virtually all industrialised countries. The limited information available from developing countries suggests that a similar epidemic is inevitable if current trends go unchecked. Treatment of patients with clinical manifestations is an important element in overall management but on its own is an insufficient and incomplete response. Sudden death is often the first manifestation of cardiovascular disease and, even when treatment of disease is applicable and effective, it is usually palliative rather than curative. Thus treatment and prevention directed at the underlying risk factors, including high blood pressure, constitute a complementary and more fundamental approach to reducing the burden of illness. Epidemiological studies provide the scientific foundation for such an approach by identifying the distribution and determinants of high blood pressure in the general population, by establishing the role of high blood pressure as a risk factor for cardiorenal complications, and by quantifying the potential value of treating and preventing high blood pressure in the general population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912348     DOI: 10.1016/s0140-6736(94)91285-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  101 in total

1.  Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women.

Authors:  Shamima Akter; Subrina Jesmin; Yoshio Iwashima; Sakuramoto Hideaki; Md Arifur Rahman; Md Majedul Islam; Masao Moroi; Nobutake Shimojo; Naoto Yamaguchi; Takashi Miyauchi; Satoru Kawano; Taro Mizutani; Yuhei Kawano
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

2.  The association of educational attainment and SBP among older community-living adults: the Maintenance of Balance, Independent Living, Intellect and Zest in the Elderly (MOBILIZE) Boston Study.

Authors:  Dan K Kiely; Alden L Gross; Dae H Kim; Lewis A Lipsitz
Journal:  J Hypertens       Date:  2012-08       Impact factor: 4.844

3.  Association between the G-protein β3 subunit C825T polymorphism with essential hypertension: a meta-analysis in Han Chinese population.

Authors:  Jiapeng Lu; Qingqing Guo; Ling Zhang; Wei Wang
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

4.  Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats.

Authors:  Gaurav Chugh; Mustafa F Lokhandwala; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

5.  High prevalence of cardiovascular risk factors among policemen in Puducherry, South India.

Authors:  Jayalakshmy Ramakrishnan; Sumanth Mallikarjuna Majgi; Kariyarath Cheriyath Premarajan; Subitha Lakshminarayanan; Susila Thangaraj; Palanivel Chinnakali
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

6.  Worldwide epidemic of hypertension.

Authors:  Arun Chockalingam; Norman R Campbell; J George Fodor
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

7.  Garlic supplementation prevents oxidative DNA damage in essential hypertension.

Authors:  Veena Dhawan; Sanjay Jain
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

8.  Association of adult socioeconomic position with hypertension in older people.

Authors:  Enrique Regidor; Juan L Gutiérrez-Fisac; José R Banegas; Vicente Domínguez; Fernando Rodríguez-Artalejo
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

9.  Subjective and objective personal noise exposure and hypertension: an epidemiologic approach.

Authors:  Tobias Weinmann; Vera Ehrenstein; Rüdiger von Kries; Dennis Nowak; Katja Radon
Journal:  Int Arch Occup Environ Health       Date:  2011-07-15       Impact factor: 3.015

Review 10.  The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.

Authors:  Yogini Ratnasabapathy; Carlene M M Lawes; Craig S Anderson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.